FAQs & How to use this site
Home | About Us | Contact Us
The Front Line
The Front Line: Charles D. Blanke, MD, SWOG Chair

PREVIOUS POSTS November 2017

October 2017 September 2017 August 2017 July 2017 June 2017 May 2017 April 2017 March 2017 February 2017 January 2017 December 2016 November 2016 October 2016 September 2016 August 2016 July 2016 JUNE 2016 MAY 2016 APRIL 2016 MARCH 2016 FEB 2016 JAN 2016 DEC 2015 NOV 2015 OCT 2015 SEP 2015 AUG 2015 JUL 2015 JUN 2015 MAY 2015 APR 2015 MAR 2015 FEB 2015 JAN 2015 DEC 2014 NOV 2014 OCT 2014 SEP 2014 AUG 2014 JUL 2014 JUN 2014 MAY 2014 APR 2014 MAR 2014 FEB 2014 JAN 2014 DEC 2013 NOV 2013 OCT 2013 SEP 2013 AUG 2013 JUL 2013

SWOG and Hope Announce a New Rare Cancers Fellowship

by Guest Blogger, Anne F. Schott, M.D., SWOG Deputy Chair and Hope Foundation Chair

Feb 6, 2015 - SWOG and The Hope Foundation are initiating a new Rare Cancers Fellowship. The Fellowship is a unique opportunity for a SWOG member to become involved in the planning and leadership of SWOG's Rare Cancers Program. By providing salary support to protect at least 25 percent of the Fellow's time, we aim to give a motivated SWOG member an opportunity to learn the mechanisms of the National Clinical Trials Network, and then to apply this knowledge to the development of rare cancer protocols that will be run in SWOG.

The Fellow will work closely with the Chair of SWOG's Early Therapeutics and Rare Cancer Committee (and other SWOG mentors) to help guide the development of rare cancer trials from concept through activation. We expect the Fellow to bring at least one rare cancer clinical trial to activation in SWOG within the two-year fellowship period.

Rare cancer research is a high-priority area of CTEP and the NCI, and the Fellow will work with these organizations and their programs, such as the International Rare Cancer Initiative and the NCI-MATCH trial, to enable clinical sites across the National Clinical Trials Network to open and accrue to SWOG rare cancer studies.

As with other programs such as our Coltman Fellowship and our Young Investigators Training Course, one of the goals of our Rare Cancer Fellowship is the development of future SWOG leaders.

Applicants should have a doctoral degree, proven experience in clinical trials development, and a faculty appointment at a SWOG member institution. Junior applicants should have a mentor currently active in SWOG.

The deadline for application for the Rare Cancers Fellowship is March 1, 2015. Application details are available online.


SWOG Logo Disclaimer | Copyright ©1999-2017 SWOG. All rights reserved.
Design and Hosting by nuMedia
SWOG is FISMA CertifiedSWOG is FISMA Certified